Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

PRC member affects blood formation during aging

Aug. 10, 2020

Keros completes dosing of planned cohorts in phase I study of KER-047

Aug. 6, 2020

Novel humanized platelet mouse model predicts efficacy of experimental antiplatelet drugs

Aug. 5, 2020

Data presented for factor XIa inhibitor milvexian in thrombosis models

Aug. 4, 2020

Src SH3 domain: an antithrombotic target without compromising homeostasis

July 31, 2020

Novel mouse model of AAA with intraluminal thrombus

July 30, 2020

INSERM presents preclinical data for single-domain antibody PS-003

July 28, 2020

FRSW-107 demonstrates extended half-life in patients with hemophilia A

July 28, 2020

FDA allows initiation of clinical trials for desidustat in chemotherapy-induced anemia

July 27, 2020

Discovery and preclinical evaluation of novel direct FXIa inhibitor, ONO-1600586

July 27, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...
Gensci-134: a long-acting growth hormone receptor agonist fusion protein
BioWorld Science
Gensci-134 (Genescience Pharmaceuticals Co. Ltd.) is a growth hormone receptor (GHR) agonist fusion protein that mimics the biological activity of growth hormone...